Standard research protocol is 2 mg/day for 6+ months to reach plateau VAT reduction
IV therapy does come with potential risks, including infection, blood clots, inflammation of the veins, and the discomfort of the needle
Research Context & Areas of Study In experimental and preclinical settings, BPC-157 has been examined for its potential interaction with: Cellular communication pathways Angiogenic and vascular response models Oxidative stress and cytoprotective research frameworks Fibroblast and connective-tissue behavior in laboratory systems Biochemical signaling processes Gastrointestinal cellular response models These observations represent laboratory-based research only and are not associated with therapeutic or clinical outcomes
Compounded drugs are not FDA-approved or evaluated for safety, effectiveness, or quality by the FDA.
Some hints on making herbal teas An infusion is best for leaves, flowers and other light parts of a plant
Such utility was of as much importance to me as the ingredients themselves